| Ms Edna E Nyang, MS, CCC-SLP | |
|
Psc 482, Fpo, AP 96362-9998 | |
| (611) 646-7723 | |
| Not Available |
| Full Name | Ms Edna E Nyang |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Psc 482, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366887606 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 14930 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Edna E Nyang, MS, CCC-SLP Psc 482, Fpo, AP 96362-9998 Ph: () - | Ms Edna E Nyang, MS, CCC-SLP Psc 482, Fpo, AP 96362-9998 Ph: (611) 646-7723 |
News Archive
Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.
A UCSF stem cell study conducted in mice suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack. The approach potentially could improve cardiac function, minimize scar size, lead to the development of new blood vessels - and avoid the risk of tissue rejection.
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers, according to an article in the September 2015 issue of The Annals of Thoracic Surgery.
Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new data at the MIT Center for Biomedical Innovation's Biomanufacturing Summit from its platform efforts aimed at developing RNAi technologies for applications in biologics manufacturing.
Increasing number of people are dying of damaged livers due to hepatitis C infection. Federal health officials are considering whether anyone born between 1945 and 1965 should get a one-time blood test to check if they are harboring the dangerous virus. Two-thirds of people with hepatitis C are in this age group, most unaware that a virus that takes a few decades to do its damage has festered since their younger days.
› Verified 8 days ago
Ms. Holly Eun Hee Gangwer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 561 Box 1877, Fpo, AP 96310 Phone: 011-827-794180 | |
Kati Conners, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 334-819-9511 | |
Mrs. Kristin Rachel Blake, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 482 Box 1600, Fpo, AP 96367 Phone: 011-816-117342747 | |
Mrs. Paige Christine Potter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6162d- Camp Lester, Fpo, AP 96362 Phone: 011-816-117468093 | |
Barbara Jean Neal, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Usnh Yokosuka Japan, Psc 475 Box 1, Fpo, AP 96350 Phone: 011-814-68165564 Fax: 011-814-68168650 | |
Kimberly Lowery, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 215-264-3402 |